Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY.
Russell MD, Galloway JB, Andrews CD, MacKenna B, Goldacre B, Mehrkar A, Curtis HJ, Butler-Cole B, O'Dwyer T, Qureshi S, Ledingham JM, Mahto A, Rutherford AI, Adas MA, Alveyn E, Norton S, Cope AP, Bechman K; OpenSAFELY Collaborative. Russell MD, et al. Among authors: alveyn e. Lancet Rheumatol. 2022 Dec;4(12):e853-e863. doi: 10.1016/S2665-9913(22)00305-8. Epub 2022 Nov 3. Lancet Rheumatol. 2022. PMID: 36447940 Free PMC article.
The infection risks of JAK inhibition.
Adas MA, Alveyn E, Cook E, Dey M, Galloway JB, Bechman K. Adas MA, et al. Among authors: alveyn e. Expert Rev Clin Immunol. 2022 Mar;18(3):253-261. doi: 10.1080/1744666X.2022.2014323. Epub 2021 Dec 29. Expert Rev Clin Immunol. 2022. PMID: 34860621 Free PMC article.
Diagnosing Camurati-Engelmann disease-the age of whole-exome sequencing.
Nagra D, Russell MD, Alveyn E, Birring SS, Elias D, Balachandran S, Galloway JB. Nagra D, et al. Among authors: alveyn e. Rheumatology (Oxford). 2023 Jul 5;62(7):e221-e222. doi: 10.1093/rheumatology/keac670. Rheumatology (Oxford). 2023. PMID: 36519831 Free PMC article. No abstract available.
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.
Russell MD, Stovin C, Alveyn E, Adeyemi O, Chan CKD, Patel V, Adas MA, Atzeni F, Ng KKH, Rutherford AI, Norton S, Cope AP, Galloway JB. Russell MD, et al. Among authors: alveyn e. Ann Rheum Dis. 2023 Aug;82(8):1059-1067. doi: 10.1136/ard-2023-224049. Epub 2023 May 29. Ann Rheum Dis. 2023. PMID: 37247942 Free PMC article.
Implementing treat-to-target urate-lowering therapy during hospitalisations for gout flares.
Russell MD, Ameyaw-Kyeremeh L, Dell'Accio F, Lapham H, Head N, Stovin C, Patel V, Clarke BD, Nagra D, Alveyn E, Adas MA, Bechman K, de la Puente MA, Ellis B, Byrne C, Patel R, Rutherford AI, Cantle F, Norton S, Roddy E, Hudson J, Cope AP, Galloway JB. Russell MD, et al. Among authors: alveyn e. Rheumatology (Oxford). 2023 Oct 31:kead574. doi: 10.1093/rheumatology/kead574. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37929968
20 results